Walleye Capital’s Japer Therapeutics Warrants JSPRW Stock Holding History

Walleye Capital’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7K	Hold	200,000	–	–	﹤0.01%	4576
2026 Q1	$4.38K	Hold	200,000	–	–	﹤0.01%	4207
2025 Q4	$8.02K	Sell	200,000 -360,061	-64%	-$40.6K	﹤0.01%	4309
2025 Q3	$44.6K	Hold	560,061	–	–	﹤0.01%	4037
2025 Q2	$70K	Hold	560,061	–	–	﹤0.01%	3925
2025 Q1	$80.1K	Sell	560,061 -13,579	-2%	-$2.15K	﹤0.01%	3700
2024 Q4	$120K	Sell	573,640 -22,374	-4%	-$4.7K	﹤0.01%	4049
2024 Q3	$119K	Hold	596,014	–	–	﹤0.01%	4320
2024 Q2	$119K	Hold	596,014	–	–	﹤0.01%	4634
2024 Q1	$108K	Sell	596,014 -99,000	-14%	-$15.7K	﹤0.01%	4352
2023 Q4	$55.6K	Sell	695,014 -5,422	-0.8%	-$450	﹤0.01%	4268
2023 Q3	$35K	Sell	700,436 -301	-0%	-$26	﹤0.01%	4277
2023 Q2	$98.2K	Buy	700,737 +45,903	+7%	+$7.07K	﹤0.01%	3444
2023 Q1	$131K	Buy	654,834 +629,775	+2,513%	+$91.9K	﹤0.01%	2780
2022 Q4	$752	Hold	25,059	–	–	﹤0.01%	3072
2022 Q3	$2K	Hold	25,059	–	–	﹤0.01%	3060
2022 Q2	$2K	Hold	25,059	–	–	﹤0.01%	2249
2022 Q1	$7K	Hold	25,059	–	–	﹤0.01%	2155
2021 Q4	$37K	Sell	25,059 -55,625	-69%	-$77.5K	﹤0.01%	1817
2021 Q3	$119K	Buy	+80,684	New	+$86.3K	﹤0.01%	1294
2021 Q1	–	Sell	-33,410	Closed	-$48K	–	1258
2020 Q4	$48K	Sell	33,410 -17,790	-35%	-$22.3K	﹤0.01%	874
2020 Q3	$57K	Buy	+51,200	New	+$51.8K	0.01%	751

Other funds holding JSPRW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Capital's JSPRW Position: Q2 2026 in Review

Walleye Capital held its Japer Therapeutics Warrants (JSPRW) position steady in Q2 2026 at 200,000 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4576.

Walleye Capital first reported a position in JSPRW in Q3 2020 and has held it in 22 quarters since. The position peaked at $131K in Q1 2023. 6 funds tracked by Wall St. Rank hold JSPRW as of Q2 2026.

Walleye Capital held 200,000 shares of Japer Therapeutics Warrants worth $2.7K as of Q2 2026.
Walleye Capital left its Japer Therapeutics Warrants share count unchanged in Q2 2026.
Japer Therapeutics Warrants made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4576 holding.
Walleye Capital first reported a position in Japer Therapeutics Warrants in Q3 2020 and has held it in 22 quarters since.
Walleye Capital's Japer Therapeutics Warrants position peaked at $131K in Q1 2023.
6 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.